Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C191716> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- NCIT_C191716 IAO_0000115 "A regimen consisting of cyclophosphamide, fludarabine, mitoxantrone and alemtuzumab that may be used in the treatment of T-cell prolymphocytic leukemia." @default.
- NCIT_C191716 NCIT_NHC0 "C191716" @default.
- NCIT_C191716 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C191716 NCIT_P108 "FMC/Alemtuzumab Regimen" @default.
- NCIT_C191716 NCIT_P208 "CL1905249" @default.
- NCIT_C191716 NCIT_R123 NCIT_C1102 @default.
- NCIT_C191716 NCIT_R123 NCIT_C129821 @default.
- NCIT_C191716 NCIT_R123 NCIT_C129822 @default.
- NCIT_C191716 NCIT_R123 NCIT_C129824 @default.
- NCIT_C191716 NCIT_R123 NCIT_C129825 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1556 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1590 @default.
- NCIT_C191716 NCIT_R123 NCIT_C163758 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1681 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1748 @default.
- NCIT_C191716 NCIT_R123 NCIT_C186664 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1908 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1909 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1913 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1915 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1933 @default.
- NCIT_C191716 NCIT_R123 NCIT_C1968 @default.
- NCIT_C191716 NCIT_R123 NCIT_C200714 @default.
- NCIT_C191716 NCIT_R123 NCIT_C20401 @default.
- NCIT_C191716 NCIT_R123 NCIT_C2114 @default.
- NCIT_C191716 NCIT_R123 NCIT_C2150 @default.
- NCIT_C191716 NCIT_R123 NCIT_C2189 @default.
- NCIT_C191716 NCIT_R123 NCIT_C253 @default.
- NCIT_C191716 NCIT_R123 NCIT_C272 @default.
- NCIT_C191716 NCIT_R123 NCIT_C274 @default.
- NCIT_C191716 NCIT_R123 NCIT_C2842 @default.
- NCIT_C191716 NCIT_R123 NCIT_C307 @default.
- NCIT_C191716 NCIT_R123 NCIT_C308 @default.
- NCIT_C191716 NCIT_R123 NCIT_C405 @default.
- NCIT_C191716 NCIT_R123 NCIT_C471 @default.
- NCIT_C191716 NCIT_R123 NCIT_C552 @default.
- NCIT_C191716 NCIT_R123 NCIT_C553 @default.
- NCIT_C191716 NCIT_R123 NCIT_C574 @default.
- NCIT_C191716 NCIT_R123 NCIT_C582 @default.
- NCIT_C191716 NCIT_R123 NCIT_C62050 @default.
- NCIT_C191716 NCIT_R123 NCIT_C697 @default.
- NCIT_C191716 NCIT_R123 NCIT_C718 @default.
- NCIT_C191716 NCIT_R123 NCIT_C72960 @default.
- NCIT_C191716 NCIT_R123 NCIT_C796 @default.
- NCIT_C191716 NCIT_R123 NCIT_C94716 @default.
- NCIT_C191716 normalizedInformationContent "100" @default.
- NCIT_C191716 referenceCount "1" @default.
- NCIT_C191716 hasExactSynonym "Alemtuzumab-FMC" @default.
- NCIT_C191716 hasExactSynonym "Alemtuzumab/Cyclophosphamide/Fludarabine/Mitoxantrone" @default.
- NCIT_C191716 hasExactSynonym "FMC Plus Alemtuzumab" @default.
- NCIT_C191716 hasExactSynonym "FMC-Alemtuzumab" @default.
- NCIT_C191716 hasExactSynonym "FMC/Alemtuzumab Regimen" @default.
- NCIT_C191716 hasExactSynonym "Fludarabine/Mitoxantrone/Cyclophosphamide/Alemtuzumab" @default.
- NCIT_C191716 inSubset NCIT_C160950 @default.
- NCIT_C191716 inSubset NCIT_C160952 @default.
- NCIT_C191716 type Class @default.
- NCIT_C191716 isDefinedBy ncit.owl @default.
- NCIT_C191716 label "FMC/Alemtuzumab Regimen" @default.
- NCIT_C191716 subClassOf B2eebf7f617ff2e02fa0cd45aac7dbb62 @default.
- NCIT_C191716 subClassOf B4b8879bb4accfdce0891bd5d097af2e2 @default.
- NCIT_C191716 subClassOf B7e38f355079d93d2d7f2bc1cf52dfcfc @default.
- NCIT_C191716 subClassOf B8e0192de27eefb9eebb27453d3a8692b @default.
- NCIT_C191716 subClassOf Ba091096364535e20daf97df2774f9898 @default.
- NCIT_C191716 subClassOf Bae34e9ba16e1d22277a20f6eb16d4a2e @default.
- NCIT_C191716 subClassOf Bbc4bb0431a2a2893d7df21868e84e610 @default.
- NCIT_C191716 subClassOf Bf802bf26ddbb97efe25150bb89314bab @default.
- NCIT_C191716 subClassOf NCIT_C12218 @default.
- NCIT_C191716 subClassOf NCIT_C173974 @default.
- NCIT_C191716 subClassOf NCIT_C186724 @default.
- NCIT_C191716 subClassOf NCIT_C191716 @default.
- NCIT_C191716 subClassOf NCIT_C62634 @default.